4//SEC Filing
Ehrnrooth Eva 4
Accession 0001140361-23-013063
CIK 0001865494other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:13 PM ET
Size
5.2 KB
Accession
0001140361-23-013063
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Ehrnrooth Eva
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-20+120,000→ 120,000 totalExercise: $1.98Exp: 2033-03-20→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on March 20, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001891333
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:13 PM ET
- Size
- 5.2 KB